Antonio Regalado
Progress in science depends on new techniques, new discoveries and new ideas, probably in that order - {Sydney Brenner}. I write about biotechniques @techreview
Last synced from Twitter 1m ago
The transhumanists who want to live forever
For a core of longevity true believers, the time to intervene is now.
Don’t change your DNA at home, says America’s first CRISPR law
A California “human biohacking” bill calls for warnings on do-it-yourself genetic engineering kits.
2
Antonio Regalado
America's has its first CRISPR law ... and it targets biohackers.
10d
What is geoengineering—and why should you care?
As the threats of climate change grow, we’re all likely to hear more and more about the possibilities, and dangers, of geoengineering. Here’s what it means.
1
Antonio Regalado
Some basics on geo-engineering technology. You're going to be hearing more about this as temperatures rise
10d
Investors keep the faith in cancer liquid biopsies
Despite slow uptake in the clinic, liquid biopsy tests incorporating methylation and other signatures are showing increasingly compelling data for non-invasive detection of cancer.
Fort Detrick lab shut down after failed safety inspection; all research halted indefinitely
All research at a Fort Detrick laboratory that handles high-level disease-causing material, such as Ebola, is on hold indefinitely after the Centers for Disease Control and Prevention found the organization
Biologist George Church apologizes for contacts with Jeffrey Epstein
The prominent scientist offered an apology for meeting with Epstein even after the financier pleaded guilty in 2008 to soliciting underage prostitution.
Scientists are making human-monkey hybrids in China
Scientists may have taken a big—and controversial—leap by mixing human cells into monkey embryos.
CRISPR baby maker explored starting a business in designer-baby tourism
He Jiankui met with US investors and entrepreneurs to discuss commercial plans for CRISPR kids.
2
Antonio Regalado
CRISPR baby maker He Jiankui explored starting a "medical tourism" company involving genetic modified babies
18d
1
Antonio Regalado
Will designer babies ever be a big business?
He Jiankui never got his chance to find out.
18d
The untold story of the ‘circle of trust’ behind the world’s first gene-edited babies
How regulations and the scientific community itself failed to stop the “rogue” Chinese scientist He Jiankui
Scientists are making human-monkey hybrids in China
In a controversial first, a team of researchers have been creating embryos that are part human and part monkey, reports the Spanish daily El País.Daring biologist: According to the newspaper, the Spanish-born biologist Juan Carlos Izpisúa Belmonte,...
5
Antonio Regalado
Biologists are making human-monkey chimeras in China, according to Spanish newspaper report.
18d
Audiences are (finally) paying more attention to climate stories
<p>For years, conventional wisdom has held that climate coverage is not especially good for business. The story always seemed too abstract, or too technical, to command attention. “It was pathetic,” David Gelber, who for decades was a producer at...
Antonio Regalado
Difficult issue explored: no one likes news about climate change. "A palpable ratings killer" cjr.org/covering_clima… h/t @charlottejee
19d
Facebook is funding brain experiments to create a device that reads your mind
Big tech firms are trying to read people’s thoughts, and no one’s ready for the consequences.
2
Antonio Regalado
Facebook's brain-interface project takes it into "human subjects" research as it finances invasive (and non invasive) brain research in academia.
20d
Sickle Cell Patient Reveals Why She Is Volunteering For Landmark Gene-Editing Study
Victoria Gray, 34, of Forest, Miss., hopes the gene-editing technique CRISPR will relieve her lifelong suffering caused by the genetic blood disorder that affects millions of people around the world.
'Like we were being forced to gamble with our son's life': Health insurers won't pay for a $2.1 million drug for kids, and parents say they're running out of time
It's "heartbreaking," one mom said, "because this one person is everything to us. And they're acting like his life doesn't really matter."
1
Antonio Regalado
Insurers denying world's most expensive drug, $2.1 mm gene therapy for spinal muscular atrophy, to patients outside (a) labelled indication and (b) what the trial demonstrated. hearbreaking stories. gimlet eye: wonder if Novartis has a hand in em
24d
A richly funded CRISPR alternative has a reproducibility problem
Researchers have cast doubt on the claims upon which Homology Medicines is built.
Antonio Regalado
can't behind this paywall, but there is a Stat+ story. Someone tell me if they credit my twitter exclusive
24d
BioCentury - Homology responds to reproducibility concerns
Homology is pushing back against a USC preprint study calling the reproducibility of the company’s cut-free gene editing platform into question. The study, which the company says stands in contrast to years of data supporting the technology,...
G: Unnatural Selection | Radiolab
A scientist launches a controversial genetic test for intelligence: what does it really tell us?
First CRISPR study inside the body to start in U.S.
The experimental treatment for an inherited form of blindness aims to supply kids and adults with a healthy version of the gene they lack.
McKinsey Advised Johnson & Johnson on Increasing Opioid Sales
In a trial in Oklahoma, records showed the firm was consulted about sales at a time when abuse of pain medicine was widespread. Cases in two other states also shed light on its role.
Antonio Regalado
Role for @McKinsey & Co. in opioid deaths. Gave advice. How to "turbocharge" sales. Take more, take longer. Won't disclose how much $ it made.
24d
Stem cell-derived clade F AAVs mediate high-efficiency homologous recombination-based genome editing
Precise genomic correction of pathogenic mutations is an attractive therapeutic strategy. Here, we show that a unique class of stem cell-derived nonpathogenic virus, hematopoietic stem cell-derived adeno-associated virus vector (AAVHSC), mediates...
1
Antonio Regalado
Here is the original efficient-gene-editing-with-just a virus result in PNAS from company's science founder pnas.org/content/115/31…
Here is the pre-print that sought to confirm the results, but did not. 3/4 biorxiv.org/content/biorxi…
25d